Geocadin Romergryko G, Wijdicks Eelco, Armstrong Melissa J, Damian Maxwell, Mayer Stephan A, Ornato Joseph P, Rabinstein Alejandro, Suarez José I, Torbey Michel T, Dubinsky Richard M, Lazarou Jason
From the Departments of Neurology, Anesthesiology-Critical Care Medicine, and Neurosurgery (R.G.G.), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Neurology (E.W., A.R.), Mayo Clinic, Rochester, MN; Department of Neurology (M.J.A.), University of Florida-McKnight Brain Institute, Gainesville; Department of Neurology and Neurocritical Care Unit (M.D.), Cambridge University Hospitals; The Ipswich Hospital (M.D.), Cambridge, UK; Departments of Neurology and Neurosurgery (S.A.M.), Mount Sinai-Icahn School of Medicine, New York, NY; Departments of Emergency Medicine and Internal Medicine (Cardiology) (J.P.O.), Virginia Commonwealth University College of Medicine, Richmond; Department of Neurology (J.I.S.), Baylor College of Medicine, Houston, TX; Department of Neurology and Neurosurgery (M.T.T.), Ohio State University, Columbus; Department of Neurology (R.M.D.), Kansas University Medical Center, Kansas City; and Department of Neurology (J.L.), University of Toronto, Canada.
Neurology. 2017 May 30;88(22):2141-2149. doi: 10.1212/WNL.0000000000003966. Epub 2017 May 10.
To assess the evidence and make evidence-based recommendations for acute interventions to reduce brain injury in adult patients who are comatose after successful cardiopulmonary resuscitation.
Published literature from 1966 to August 29, 2016, was reviewed with evidence-based classification of relevant articles.
For patients who are comatose in whom the initial cardiac rhythm is either pulseless ventricular tachycardia (VT) or ventricular fibrillation (VF) after out-of-hospital cardiac arrest (OHCA), therapeutic hypothermia (TH; 32-34°C for 24 hours) is highly likely to be effective in improving functional neurologic outcome and survival compared with non-TH and should be offered (Level A). For patients who are comatose in whom the initial cardiac rhythm is either VT/VF or asystole/pulseless electrical activity (PEA) after OHCA, targeted temperature management (36°C for 24 hours, followed by 8 hours of rewarming to 37°C, and temperature maintenance below 37.5°C until 72 hours) is likely as effective as TH and is an acceptable alternative (Level B). For patients who are comatose with an initial rhythm of PEA/asystole, TH possibly improves survival and functional neurologic outcome at discharge vs standard care and may be offered (Level C). Prehospital cooling as an adjunct to TH is highly likely to be ineffective in further improving neurologic outcome and survival and should not be offered (Level A). Other pharmacologic and nonpharmacologic strategies (applied with or without concomitant TH) are also reviewed.
评估在成功进行心肺复苏后昏迷的成年患者中,为减少脑损伤而采取急性干预措施的证据,并提出基于证据的建议。
回顾了1966年至2016年8月29日发表的文献,并对相关文章进行了循证分类。
对于院外心脏骤停(OHCA)后初始心律为无脉性室性心动过速(VT)或心室颤动(VF)且昏迷的患者,与非治疗性低温(TH)相比,治疗性低温(32 - 34°C持续24小时)极有可能有效改善神经功能结局和生存率,应予以采用(A级)。对于OHCA后初始心律为VT/VF或心脏停搏/无脉性电活动(PEA)且昏迷的患者,目标温度管理(36°C持续24小时,随后8小时复温至37°C,并将温度维持在37.5°C以下直至72小时)可能与TH效果相同,是一种可接受的替代方法(B级)。对于初始心律为PEA/心脏停搏且昏迷的患者,与标准治疗相比,TH可能改善出院时的生存率和神经功能结局,可以考虑采用(C级)。院前降温作为TH的辅助措施极有可能无法进一步改善神经功能结局和生存率,不应采用(A级)。还对其他药物和非药物策略(无论是否同时进行TH)进行了综述。